首页|期刊导航|中华医学杂志（英文版）|Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

Qin Yazhen Lu Jin Bao Li Zhu Honghu Li Jinlan Li Lingdi Lai Yueyun

中华医学杂志（英文版）2014，Vol.127Issue(9)：1666-1671,6.

中华医学杂志（英文版）2014，Vol.127Issue(9)：1666-1671,6.DOI:10.3760/cma.j.issn.0366-6999.20132356

Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

Qin Yazhen ¹Lu Jin ¹Bao Li ¹Zhu Honghu ¹Li Jinlan ¹Li Lingdi ¹Lai Yueyun¹

作者信息

1. Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China
折叠

摘要

关键词

multiple myeloma/ preferentially expressed antigen of melanoma expression/ bortezomib/ progression-free survival/ real-time quantitative polymerase chain reaction

Key words

multiple myeloma/ preferentially expressed antigen of melanoma expression/ bortezomib/ progression-free survival/ real-time quantitative polymerase chain reaction

引用本文复制引用

Qin Yazhen,Lu Jin,Bao Li,Zhu Honghu,Li Jinlan,Li Lingdi,Lai Yueyun..Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma[J].中华医学杂志（英文版）,2014,127(9):1666-1671,6.

基金项目

This work was supported by the Beijing Municipal Science and Technology Program (No.Z111107067311070) and Nature Science Foundation of China (No.81170483 and 81372535). （No.Z111107067311070）

中华医学杂志（英文版）

OACSCDCSTPCD

ISSN：0366-6999

访问量0

下载量0

段落导航